Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism

被引:15
作者
Burrows, SR
Khanna, R
Moss, DJ
机构
[1] Queensland Inst Med Res, Bancroft Ctr, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Joint Oncol Program, Brisbane, Qld, Australia
关键词
D O I
10.1182/blood.V93.3.1020.403k06_1020_1024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alloreactive T lymphocytes that respond directly to foreign major histocompatibility complex (MHC) molecules and bound peptide are known to be central mediators of graft-versus-host disease (GVHD) and allograft rejection. We have recently identified a peptide from the human protein, cytochrome P450 (isotypes IIC9, 10, or 18), that is recognized in association with human leukocyte antigen (HLA) B*3501 by alloreactive cytotoxic T lymphocytes (CTLs), These CTLs with this specificity were isolated from several unrelated individuals and were found to express a common T-cell receptor (ICR), Synthetic analogs of the cytochrome P450 peptide were generated by introducing single amino acid substitutions at putative TCR contact positions. Four altered peptide ligands were powerful competitive antagonists of these CTL clones, reducing lysis levels of target cells expressing the alloantigen HLA B*3501 by over 80%, This first demonstration that it is possible to suppress CTL alloreactivity with structural variants of allodeterminants raises the prospect that such TCR antagonists could be exploited within the clinical arena to specifically modulate GVHD and allograft rejection. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:1020 / 1024
页数:5
相关论文
共 26 条
[1]  
APPLETON AL, 1993, BONE MARROW TRANSPL, V11, P349
[2]   Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity [J].
Burrows, SR ;
Silins, SL ;
Khanna, R ;
Burrows, JM ;
Rischmueller, M ;
McCluskey, J ;
Moss, DJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (07) :1726-1736
[3]   AN ALLORESPONSE IN HUMANS IS DOMINATED BY CYTOTOXIC T-LYMPHOCYTES (CTL) CROSS-REACTIVE WITH A SINGLE EPSTEIN-BARR-VIRUS CTL EPITOPE - IMPLICATIONS FOR GRAFT-VERSUS-HOST DISEASE [J].
BURROWS, SR ;
KHANNA, R ;
BURROWS, JM ;
MOSS, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1155-1161
[4]  
Colovai AI, 1997, J IMMUNOL, V158, P48
[5]  
Daniel C, 1998, J IMMUNOL, V160, P3244
[6]   ANTIGEN ANALOG MAJOR HISTOCOMPATIBILITY COMPLEXES ACT AS ANTAGONISTS OF THE T-CELL RECEPTOR [J].
DEMAGISTRIS, MT ;
ALEXANDER, J ;
COGGESHALL, M ;
ALTMAN, A ;
GAETA, FCA ;
GREY, HM ;
SETTE, A .
CELL, 1992, 68 (04) :625-634
[7]  
DIETRICH PY, 1994, BLOOD, V84, P2815
[8]  
FINN OJ, 1989, TRANSPLANT P, V21, P346
[9]   T-CELL RECEPTOR ANTAGONIST PEPTIDES ARE HIGHLY EFFECTIVE INHIBITORS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
FRANCO, A ;
SOUTHWOOD, S ;
ARRHENIUS, T ;
KUCHROO, VK ;
GREY, HM ;
SETTE, A ;
ISHIOKA, GY .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) :940-946
[10]   CLONAL ANALYSIS OF GRAFT-INFILTRATING LYMPHOCYTES FROM RENAL AND CARDIAC BIOPSIES - DOMINANT REARRANGEMENTS OF TCR-BETA GENES AND PERSISTENCE OF DOMINANT REARRANGEMENTS IN SERIAL BIOPSIES [J].
FRISMAN, DM ;
HURWITZ, AA ;
BENNETT, WT ;
BOYLE, LA ;
FALLON, JT ;
DEC, GW ;
COLVIN, RB ;
KURNICK, JT .
HUMAN IMMUNOLOGY, 1990, 28 (02) :208-215